Key result
Watchman FLX achieves ~95% procedural success with no major periprocedural complications.
Why the study?
The Watchman FLX is a new generation of left atrial appendage closure device with several new features compared to the previous generation, and the authors aimed to collect the first clinical data on its implantation techniques, procedural success, complications, and patient outcomes.
Observational (n=19)
Open-label
No
Reviews design features and early clinical experience of the Watchman FLX device for left atrial appendage closure, indicating improved procedural adaptability.
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Grygier M, Olasińska-Wiśniewska A, Araszkiewicz A, Trojnarska O, Babicz-Sadowska A, Lesiak M. The Watchman FLX – a new device for left atrial appendage occlusion – design, potential benefits and first clinical experience. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2017;13(1):62-66. doi:10.5114/aic.2017.66188. APA Grygier, M., Olasińska-Wiśniewska, A., Araszkiewicz, A., Trojnarska, O., Babicz-Sadowska, A., & Lesiak, M. (2017). The Watchman FLX – a new device for left atrial appendage occlusion – design, potential benefits and first clinical experience. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 13(1), 62-66. https://doi.org/10.5114/aic.2017.66188 Chicago Grygier, Marek, Anna Olasińska-Wiśniewska, Aleksander Araszkiewicz, Olga Trojnarska, Anna Babicz-Sadowska, and Maciej Lesiak. 2017. "The Watchman FLX – a new device for left atrial appendage occlusion – design, potential benefits and first clinical experience". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 13 (1): 62-66. doi:10.5114/aic.2017.66188. Harvard Grygier, M., Olasińska-Wiśniewska, A., Araszkiewicz, A., Trojnarska, O., Babicz-Sadowska, A., and Lesiak, M. (2017). The Watchman FLX – a new device for left atrial appendage occlusion – design, potential benefits and first clinical experience. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 13(1), pp.62-66. https://doi.org/10.5114/aic.2017.66188 MLA Grygier, Marek et al. "The Watchman FLX – a new device for left atrial appendage occlusion – design, potential benefits and first clinical experience." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 13, no. 1, 2017, pp. 62-66. doi:10.5114/aic.2017.66188. Vancouver Grygier M, Olasińska-Wiśniewska A, Araszkiewicz A, Trojnarska O, Babicz-Sadowska A, Lesiak M. The Watchman FLX – a new device for left atrial appendage occlusion – design, potential benefits and first clinical experience. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2017;13(1):62-66. doi:10.5114/aic.2017.66188.
No takes yet. Share an insight, caveat, or question.
Grygier et al. (2017) conducted an observational in Atrial fibrillation with contraindications for oral anticoagulation (n=19). Watchman FLX left atrial appendage closure device was evaluated on Procedural success of left atrial appendage occlusion. Watchman FLX left atrial appendage occlusion was successful in 18 of 19 patients (94.7%) with no periprocedural strokes, device embolizations, or pericardial effusions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: